文献速递内脏/肾动脉与血管畸形

肾动脉瘤开放与腔内治疗的单中心经验

Single Centre Experience in Open and Endovascular Treatment of Renal Artery Aneurysms.
PubMed 文献 · Ann Vasc Surg · 2021-10-10

单中心15年回顾性研究纳入27例肾动脉瘤患者,开放手术14例、腔内栓塞13例。两种技术均安全有效,开放手术早期并发症更多,但随访中肾小球滤过率下降未达统计学意义。

要点

  • 开放手术与腔内栓塞均可有效隔绝肾动脉瘤并保持肾动脉通畅。
  • 开放手术早期并发症较多,腔内治疗住院期间仅1例出现并发症。
  • 修复肾动脉瘤未改善血压控制或减少降压药需求。

核心结论

  • 开放手术与腔内技术治疗肾动脉瘤均安全有效,但开放手术并发症率较高。
  • 术式选择应依据动脉瘤解剖特征、直径、位置及累及肾分支数量。

研究设计与样本

  • 单中心回顾性观察研究,纳入15年间所有接受开放或腔内治疗的肾动脉瘤患者。
  • 共27例患者,女17例(63%),平均年龄58±13.2岁,囊状动脉瘤26例。
  • 平均动脉瘤直径18.8±6.3毫米,开放手术14例(51.8%),腔内弹簧圈栓塞13例(48.2%)。

主要发现

  • 平均住院5.4±3.6天,仅开放手术患者需重症监护,平均1.1±1.2天。
  • 早期并发症开放组7/14例,腔内组1/13例,包括出血、腹膜后血肿、动脉血栓形成和肠梗阻。
  • 出院影像显示所有病例动脉瘤完全隔绝且肾动脉通畅。
  • 平均随访39±42个月,3例(11%)失访,2例(7.4%)死于无关原因,无患者需透析。
  • 术前至末次随访肾小球滤过率下降,P=0.09。

临床怎么用

  • 根据动脉瘤解剖特征、直径、位置及累及肾分支数量个体化选择开放或腔内修复。
  • 腔内治疗早期并发症较少,但需更大规模研究明确其广泛应用的可行性与安全性。
  • 术后需监测肾功能变化,尽管本组无透析依赖病例。

局限性

  • 单中心回顾性研究,样本量小(27例),随访时间变异大。
  • 原文未报告两组间肾功能下降的具体数值及统计比较细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The true incidence and natural history of renal artery aneurysm (RAA) remain unclear and still exists controversy over indication for treatment. Several techniques of conventional surgical reconstructions are described in literature, and more recently endovascular therapies have been reported with satisfying results and lower complication rate. This paper aims to investigate the outcomes of both endovascular and open repair of RAA achieved in a single institution involving 3 medical teams (urology, vascular surgery and neuroradiology). MATERIAL AND METHODS: We conducted a single-centre retrospective observational study about all patients surgically or endovascularly treated for RAA over a 15-year period. Pre-operative, procedural and post-operative data at the early, mid- and long-term follow-up were collected and analysed, focusing on operative technique used for repair and related outcomes. RESULTS: A total of 27 patients (n = 17 (63%) women, mean age 58 ± 13.2, n = 26 saccular RAA) were included. Mean aneurysm was size was 18.8 ± 6.3 mm. Most diagnosis were accidental. Symptomatic RAA showed with macroscopic haematuria (n = 3, 25.9%), unstable hypertension (n = 2; 7%), chronic lumbar pain (n = 1, 3.7%) and renal infarct (n = 1, 3.7%). Conventional surgery (ex-vivo repair, aneurysmorraphy, aneurysm resection and end-to-end anastomosis) was performed in 14 (51.8%) cases and endovascular coiling embolization in 13 (48.2%). Mean hospital length of stay was 5.4 ± 3.6 days. Intensive Care Unit stay was needed only in the surgically treated patients (mean 1.1 ± 1.2 days). During the early follow-up, morbidity rate was 7/14 in surgically treated patients vs. 1/13 in endovascular group; it included bleeding, retroperitoneal hematoma, arterial thrombosis and bowel obstruction. The discharge imaging showed complete aneurysm exclusion and renal artery patency in all cases. At a mean follow-up of 39 ± 42 months, 3 patients (11%) were lost to follow up and 2 (7.4 %) died from unrelated cause. None of these patients required dialysis but a statistically significant (P = 0.09) decrease in GFR was noted between the preoperative period and last follow-up control. RAA repair neither showed blood pressure control improvement nor reduced the need for anti-hypertensive drug use. CONCLUSION: Open or endovascular techniques are both safe and efficient to treat RAA. Even though, surgical management is burdened with higher morbidity rate, the operative technique should be selected according to anatomical features, diameters and location of RRA; and the number of renal branches involved. Further larger studies are needed to define the feasibility and safety for a wider application of the endovascular approach.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Laurin T, Borghese O, Branchereau J, et al. Single Centre Experience in Open and Endovascular Treatment of Renal Artery Aneurysms. Ann Vasc Surg. 2021. PMID: 34644627. doi:10.1016/j.avsg.2021.07.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。